Results 171 to 180 of about 980,683 (314)

Basal Cell Carcinoma of the Cloacal Aperture in a Red Kangaroo (<i>Osphranter rufus</i>). [PDF]

Vet Sci
van der Weyden L, Fitte A, O'Dell N.
europepmc   +1 more source

Modeling hepatic fibrosis in TP53 knockout iPSC‐derived human liver organoids

Molecular Oncology, EarlyView.
This study developed iPSC‐derived human liver organoids with TP53 gene knockout to model human liver fibrosis. These organoids showed elevated myofibroblast activation, early disease markers, and advanced fibrotic hallmarks. The use of profibrotic differentiation medium further amplified the fibrotic signature seen in the organoids.
Mustafa Karabicici, Soheil Akbari, Ceyda Caliskan, Canan Celiker, Ozden Oz, Leman Binokay, Gökhan Karakulah, Serif Senturk, Esra Erdal   +8 more
wiley   +1 more source

Keratotic Basal Cell Carcinoma With Matrical Differentiation on the Flank: A Case Report. [PDF]

Cureus
Vemugunta V, Robins D.
europepmc   +1 more source

Ecofriendly Cellulose Substrate‐Based Flexible Transparent Electrode for Flexible Organic Solar Cells with Efficiency Over 18% [PDF]

Zheng Xiao, Shitong Li, Jian Liu, Xin Chen, Zhaochen Suo, Chenxi Li, Xiangjian Wan, Yongsheng Chen   +7 more
openalex   +1 more source

PYCR1 inhibition in bone marrow stromal cells enhances bortezomib sensitivity in multiple myeloma cells by altering their metabolism

Molecular Oncology, EarlyView.
This study investigated how PYCR1 inhibition in bone marrow stromal cells (BMSCs) indirectly affects multiple myeloma (MM) cell metabolism and viability. Culturing MM cells in conditioned medium from PYCR1‐silenced BMSCs impaired oxidative phosphorylation and increased sensitivity to bortezomib.
Inge Oudaert, Lauren van den Broecke, Osman Aksoy, Judith Lind, Sonia Vallet, Arne Van der Vreken, Gamze Ates, Ann Massie, Ken Maes, Kim De Veirman, Elke De Bruyne, Karin Vanderkerken, Klaus Podar, Eline Menu   +13 more
wiley   +1 more source

Carcinoma basocelular de vulva: relato de caso

Revista Brasileira de Cirurgia Plástica
MARIA CLARA AMORIM-SILVA, RAFAEL EVERTON ASSUNÇÃO-RIBEIRO-DA COSTA, ERLAN CLAYTON XAVIER-CAVALCANTE, ESTER SOARES- BATISTA-DA COSTA, ANA MARIA LIMA- FURTADO-VELOSO, SABAS CARLOS VIEIRA   +5 more
doaj   +1 more source

Basal cell carcinoma risk prediction in survivors of childhood cancer. [PDF]

J Natl Cancer Inst
Im C, Boull C, Lu Z, Liao K, Hasan H, Xu L, Sapkota Y, Howell RM, Arnold MA, Conces MR, Housten AJ, Gebauer J, Langer T, Teepen JC, Kremer LCM, Constine LS, Yasui Y, Hudson MM, Ness KK, Armstrong GT, Neglia JP, Yuan Y, Turcotte LM.   +22 more
europepmc   +1 more source

Spectroscopic study of the morphology development of closed-cell polyurethane foam using bio-based malonic acid as chain extender

, 2020
Weiwei Zhao, Bradford Nolan, Harry Bermudez, Shaw Ling Hsu, Umesh Choudhary, Johan van Walsem   +5 more
openalex   +1 more source

Ontology based molecular signatures for immune cell types via gene expression analysis [PDF]

, 2013
Terrence F. Meehan, Nicole Vasilevsky, Chris Mungall, David S. Dougall, Melissa Haendel, Judith A. Blake, Alexander D. Diehl   +6 more
openalex   +1 more source

In vitro properties of patient serum predict clinical outcome after high dose rate brachytherapy of hepatocellular carcinoma

Molecular Oncology, EarlyView.
Following high dose rate brachytherapy (HDR‐BT) for hepatocellular carcinoma (HCC), patients were classified as responders and nonresponders. Post‐therapy serum induced increased BrdU incorporation and Cyclin E expression of Huh7 and HepG2 cells in nonresponders, but decreased levels in responders.
Lukas Salvermoser, Jan Niklas Schäfer, Shraga Nahum Goldberg, Philipp Maximilian Kazmierczak, Moritz Nikolaus Gröper, Philipp Franz Linden, Elif Öcal, Tanja Burkard, Stefanie Corradini, Najib Ben Khaled, Moritz Wildgruber, Max Seidensticker, Jens Ricke, Matthias Stechele, Marianna Alunni‐Fabbroni   +14 more
wiley   +1 more source